Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesReporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine
British Journal of Clinical Pharmacology, 09/08/09
Tavassoli N et al. – Among the three step 2 analgesic combinations, reporting rate and 'seriousness' of ADRs are the highest with TRM+P and the lowest with COD+P. The study suggests that the safety profile of DXP+P is worst than that of COD+P.
Related Articles
The CD40–CD154 co-stimulation pathway mediates innate immune injury in adriamycin nephrosis
Nephrology Dialysis Transplantation, 11/05/09
Relevance Score: 80%%
Overexpression and involvement of special AT-rich sequence binding protein 1 in multidrug resistance in human breast carcinoma cells
Cancer Science, 11/02/09
Relevance Score: 80%%
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain
Journal of Orthopaedics and Traumatology, 11/24/09
Enzyme therapy in Fabry disease: severe adverse events associated with anti-agalsidase cross-reactive IgG antibodies
British Journal of Clinical Pharmacology, 11/24/09
Appraising the post-marketing safety of medicines: A description of national and international pharmacovigilance with a focus on medicines used in chronic pain
Current Anaesthesia and Critical Care, 11/24/09
Sponsor
Article Search
Sponsor